USANA Health Sciences (USNA) Misses Q4 EPS by 25c
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $14.76 +1.86%
Revenue Growth %: +5.0%
Financial Fact:
Interest income: 338K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +5.0%
Financial Fact:
Interest income: 338K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q4 EPS of $1.03, $0.25 worse than the analyst estimate of $1.28. Revenue for the quarter came in at $267 million versus the consensus estimate of $271.93 million.
GUIDANCE:
USANA Health Sciences sees FY2022 EPS of $5.25-$6.00, versus the consensus of $5.78. USANA Health Sciences sees FY2022 revenue of $1.125-1.225 billion, versus the consensus of $1.17 billion.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- Premarket movers: Quest, Labcorp hit by CMS cuts
- AutoZone beats profit view but misses on revenue
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
